Trial Profile
Clinical Trial of Sofosbuvir/Ribavirin for HCV Genotype 2-infected Japanese Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Aug 2015 New trial record